BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32211104)

  • 1. TTLL12 expression in ovarian cancer correlates with a poor outcome.
    Yang S; Liang Y; Qian H; Li Q
    Int J Clin Exp Pathol; 2020; 13(2):239-247. PubMed ID: 32211104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Wen R; Xiao Y; Zhang Y; Yang M; Lin Y; Tang J
    Oncol Rep; 2016 Dec; 36(6):3172-3180. PubMed ID: 27748896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library.
    Deshpande A; Brants J; Wasylyk C; van Hooij O; Verhaegh GW; Maas P; Schalken JA; Wasylyk B
    PLoS One; 2024; 19(2):e0296960. PubMed ID: 38394155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of TTLL12 on tubulin tyrosine nitration as a novel target for screening anticancer drugs
    Xue L; Zeng Y; Fang C; Cheng W; Li Y
    Oncol Lett; 2020 Dec; 20(6):340. PubMed ID: 33123251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.
    Wasylyk C; Zambrano A; Zhao C; Brants J; Abecassis J; Schalken JA; Rogatsch H; Schaefer G; Pycha A; Klocker H; Wasylyk B
    Int J Cancer; 2010 Dec; 127(11):2542-53. PubMed ID: 20162578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTLL12 is required for primary ciliary axoneme formation in polarized epithelial cells.
    Ceglowski J; Hoffman HK; Hoff KJ; McCurdy BL; Moore JK; Prekeris R
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Yang M; Xie X; Ding Y
    Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer.
    Chen ZJ; Zhang Z; Xie BB; Zhang HY
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3373-7. PubMed ID: 27608895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
    Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
    Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
    Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
    Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer.
    Yao S; Shang W; Huang L; Xu R; Wu M; Wang F
    J Cancer; 2021; 12(3):630-643. PubMed ID: 33403023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer.
    Liu N; Zhang J; Zhang LY; Wang L
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3713-3718. PubMed ID: 29949144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis.
    Fang YN; Huang ZL; Li H; Tan WB; Zhang QG; Wang L; Wu JL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5127-5133. PubMed ID: 30178832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.